LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 1981 | 4935 | 0.4015 | 0.2403 |
MDA-MB-231 | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1938 | 4935 | 0.3927 | 0.2256 |
MDA-MB-231 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1873 | 4935 | 0.3798 | 0.2049 |
MDA-MB-231 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1311 | 1562 | 4935 | 0.3165 | 0.0942 |
MDA-MB-231 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1311 | 4997 | 4935 | 1.0126 | 1.0126 |
MDA-MB-231 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4641 | 4935 | 0.9403 | 0.9363 |
MDA-MB-231 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4824 | 4935 | 0.9774 | 0.9754 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 5080 | 4935 | 1.0294 | 1.0305 |
MDA-MB-231 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4776 | 4935 | 0.9676 | 0.9655 |
MDA-MB-231 | Sorafenib | 10 | uM | LJP6 | 72 | hr | 1311 | 4434 | 4935 | 0.8982 | 0.8903 |
MDA-MB-231 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1311 | 5276 | 5079 | 1.0390 | 1.0396 |
MDA-MB-231 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5059 | 5079 | 0.9962 | 0.9962 |
MDA-MB-231 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 5060 | 5079 | 0.9965 | 0.9963 |
MDA-MB-231 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4932 | 5079 | 0.9711 | 0.9699 |
MDA-MB-231 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4685 | 5079 | 0.9224 | 0.9190 |
MDA-MB-231 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1311 | 4231 | 5079 | 0.8332 | 0.8213 |
MDA-MB-231 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1311 | 4619 | 5079 | 0.9094 | 0.9048 |
MDA-MB-231 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4723 | 5079 | 0.9297 | 0.9263 |
MDA-MB-231 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4803 | 5079 | 0.9454 | 0.9429 |
MDA-MB-231 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4707 | 5079 | 0.9268 | 0.9236 |
MDA-MB-231 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4638 | 5079 | 0.9132 | 0.9091 |
MDA-MB-231 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1311 | 4417 | 5079 | 0.8693 | 0.8611 |
MDA-MB-231 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1311 | 2608 | 4935 | 0.5284 | 0.4309 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 866 | 4935 | 0.1756 | -0.1954 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 761 | 4935 | 0.1542 | -0.2480 |